Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 10/20 | 0.44 |
| ▸ | PTPRB | P23467 | 1/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | PTEN | P60484 | 1/20 | 0.43 |
| ▸ | PTPMT1 | Q8WUK0 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 2/20 | 0.39 |
| ▸ | RXRB | P28702 | 2/20 | 0.39 |
| ▸ | RXRG | P48443 | 2/20 | 0.39 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.38 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.38 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26625541 | 0.87 | FFAR1 (0.44) | FFAR1PTPRBCDC25ACDC25BPTEN | |
| SCHEMBL585323 | 0.83 | KDM4E (0.46) | CA2 | |
| SCHEMBL29482417 | 0.83 | KDM4E (0.46) | CA2 | |
| SCHEMBL6911329 | 0.76 | CNR1 (0.40) | CA2 | |
| SCHEMBL20680969 | 0.74 | RXRA (0.57) | FFAR1PTPRBCDC25ACDC25BPTEN | |
| SCHEMBL30263704 | 0.74 | RXRA (0.57) | FFAR1PTPRBCDC25ACDC25BPTEN | |
| SCHEMBL112142 | 0.74 | TBXAS1 (0.39) | FFAR1 | |
| SCHEMBL6909899 | 0.73 | SKP2 (0.42) | CA1CA2 | |
| SCHEMBL81133 | 0.73 | — | — | |
| SCHEMBL11111979 | 0.73 | RXRB (0.64) | FFAR1KEAP1FFAR4RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-4045490-B1 | NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES | SYMRISE AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| EP-3684898-B1 | METHOD FOR PRODUCING AN ACTIVE SUBSTANCE WAFER | SYMRISE AG (DE) | 2025-04-30 | — | — | EP | disclosed |
| EP-4006130-B1 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | SYMRISE AG (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-3924102-B1 | METHOD FOR PRODUCING MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| EP-3969163-B1 | BIODEGRADABLE POLYUREA/POLYURETHANE MICROCAPSULES | SYMRISE AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| EP-4472763-A1 | METHOD FOR PRODUCING MICROCAPSULES | Symrise AG (DE) | 2024-12-11 | — | — | EP | disclosed |
| WO-2002051375-A1 | SELECTION METHOD FOR ODOROUS SUBSTANCES | HAARMANN & REIMER GMBH (DE) | 2002-07-04 | — | — | WO | disclosed |
| EP-1215189-A1 | Process for the preparation of isolongifolanol | HAARMANN & REIMER GMBH (DE) | 2002-06-19 | — | — | EP | disclosed |
| WO-2002024857-A1 | MULTI-PHASE SOAP | HAARMANN & REIMER GMBH (DE) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002019983-A2 | CLEANSING/CONDITIONING AGENTS CONTAINING MATRIX PARTICLES WITH A PERFUME COMPONENT AND A WASHING-ACTIVE COMPONENT | HAARMANN & REIMER GMBH (DE) | 2002-03-14 | — | — | WO | disclosed |
| WO-2002012157-A1 | NOVEL MACROCYCLIC KETONES | HAARMANN & REIMER GMBH (DE) | 2002-02-14 | — | — | WO | disclosed |
| EP-1111029-A2 | Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one | HAARMANN & REIMER GMBH (DE) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001038440-A1 | WAX FORMULATIONS CONTAINING ODORIFEROUS SUBSTANCES | HAARMANN & REIMER GMBH (DE) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001023373-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | FFAR1 1507/4885PTPRB 358/4885CDC25A 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.